Skip to main content

Published locations for Satralizumab monotherapy reduces NMOSD relapse rate

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Satralizumab monotherapy reduces NMOSD relapse rate

User login

  • Reset your password
  • /content/satralizumab-monotherapy-reduces-nmosd-relapse-rate
  • /neurologyreviews/article/222252/multiple-sclerosis/satralizumab-monotherapy-reduces-nmosd-relapse
  • /neurology/article/222252/multiple-sclerosis/satralizumab-monotherapy-reduces-nmosd-relapse-rate
  • /breast-cancer-icymi/article/222252/multiple-sclerosis/satralizumab-monotherapy-reduces-nmosd-relapse
  • /b-cell-lymphoma-icymi/article/222252/multiple-sclerosis/satralizumab-monotherapy-reduces-nmosd